Citation 1665

CHEN,FC: PENG,CF: TSAI,IL: CHEN,IS:. (2005). ANTITUBERCULAR CONSTITUENTS FROM THE STEM WOOD OF CINNAMOMUM KOTOENSE. 68(9)

Citation Details

Title	ANTITUBERCULAR CONSTITUENTS FROM THE STEM WOOD OF CINNAMOMUM KOTOENSE
Authors	CHEN,FC: PENG,CF: TSAI,IL: CHEN,IS:
Year	2005
Volume	68
Issue	9

Summary

Year: 2005

Journal: Unknown

Organisms and Their Experiments (1)

Cinnamomum kotoense (LAURACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KOTOLACTONE A	ACTIVE
2	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KOTOLACTONE A	None
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KOTOLACTONE B	None
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KOTOMOLIDE,SECO:	None
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KOTODIOL	None
6	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KOTODIOL	EQUIVOCAL
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FURAN,2-ACETYL-5-DODECYL:	None
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OBTUSILACTONE A	None
9	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSILACTONE A	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OF	LINCOMOLIDE B	None
11	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LINCOMOLIDE B	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVAN-3-OL,4'-HYDROXY-3'-5-7-TRIMETHOXY:	None
13	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN-3-OL,4'-HYDROXY-3'-5-7-TRIMETHOXY:	EQUIVOCAL
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SYRINGARESINOL,(DL):	None
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SYRINGALDEHYDE	None
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VANILLIN	None
17	Not specified	ISOLATION AND IDENTIFICATION OF	BENZALDEHYDE,4-HYDROXY:	None
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PROTOCATECHUIC ACID	None
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZOIC ACID	None
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTEROL,BETA:	None
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTEROL	None
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAUCOSTEROL	None
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTEROL-3-O-BETA-D-GLUCOSIDE	None
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FURAN,2-ACETYL-5-METHYL:	None
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PALMITIC ACID METHYL ESTER	None
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STEARIC ACID METHYL ESTER	None
27	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LAURIC ACID	None
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PALMITIC ACID	None
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MARGARIC ACID	None
30	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	APIGENIN	None
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL	None
32	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN	None
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GENKWANIN	None
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CATECHIN,(+):	None
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CATECHIN,(-):	None
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVAN-3-OL,4'-HYDROXY-3'-5-7-TRIMETHOXY: (-):	None
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SESAMIN,(-):	None
38	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FERULIC ACID,TRANS:	None
39	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	COUMARIC ACID,TRANS:	None
40	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZOQUINONE,1-4: 2-6-DIMETHOXY:	None
41	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTENONE	None
42	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SQUALENE	None
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHYTOL,TRANS:	None
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BEHENIC ACID	None
45	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TETRACOSANE,N:	None
46	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STEARIC ACID	None
47	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-4-22-DIEN-3-ONE	None
48	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STEARIC ACID	ACTIVE
49	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARGARIC ACID	ACTIVE
50	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	ACTIVE
51	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAURIC ACID	WEAK ACTIVITY
52	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STEARIC ACID METHYL ESTER	WEAK ACTIVITY
53	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID METHYL ESTER	WEAK ACTIVITY
54	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FURAN,2-ACETYL-5-METHYL:	INACTIVE
55	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL-3-O-BETA-D-GLUCOSIDE	WEAK ACTIVITY
56	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAUCOSTEROL	WEAK ACTIVITY
57	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STIGMASTEROL	WEAK ACTIVITY
58	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	WEAK ACTIVITY
59	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID	INACTIVE
60	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	None
61	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZALDEHYDE,4-HYDROXY:	INACTIVE
62	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	WEAK ACTIVITY
63	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGALDEHYDE	EQUIVOCAL
64	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL,(DL):	EQUIVOCAL

Citation 1665

Citation Details

Summary

Organisms and Their Experiments (1)

Cinnamomum kotoense (LAURACEAE)

Show SPARQL Queries (1)

Query 1